首站-论文投稿智能助手
典型文献
Retinal microglial activation in glaucoma: evolution over time in a unilateral ocular hypertension model
文献摘要:
Glaucoma is a neurodegenerative chronic pathology, characterized by the loss of retinal ganglion cells (RGC), which leads to an irreversible vision field loss. The increased intraocular pressure (IOP) constitutes its main risk factor. Nowadays, the main treatments for glaucoma are focused on decreasing IOP; nevertheless, the progression of the disease continues, despite IOP control. This fact shows the existence of other factors that could contribute to the advance of glaucomatous neurodegeneration. The early diagnostics, the use of neuroprotective therapies, and knowledge of the pathological processes are the major challenges associated with the management of this disease. Different pathogenic mechanisms have been proposed to be responsible for RGC death, including oxidative stress, mitochondrial dysfunction, glutamate excitotoxicity, and neuroinflammation (Casson et al., 2012).
文献关键词:
作者姓名:
José A.Fernández-Albarral
作者机构:
Instituto de Investigaciones Oftalmológicas Ramón Castroviejo,Universidad Complutense de Madrid,Madrid,Spain;Facultad de óptica y Optometría,Departamento de Inmunología,Oftalmología y ORL,Universidad Complutense de Madrid,Madrid,Spain
引用格式:
[1]José A.Fernández-Albarral-.Retinal microglial activation in glaucoma: evolution over time in a unilateral ocular hypertension model)[J].中国神经再生研究(英文版),2022(04):797-799
A类:
glaucomatous
B类:
Retinal,microglial,activation,evolution,over,unilateral,hypertension,model,Glaucoma,neurodegenerative,chronic,pathology,characterized,by,loss,retinal,ganglion,cells,RGC,which,leads,irreversible,vision,field,increased,intraocular,pressure,IOP,constitutes,its,main,risk,Nowadays,treatments,are,focused,decreasing,nevertheless,progression,disease,continues,despite,control,This,shows,existence,other,factors,that,could,contribute,advance,neurodegeneration,early,diagnostics,neuroprotective,therapies,knowledge,pathological,processes,major,challenges,associated,management,this,Different,pathogenic,mechanisms,have,been,proposed,responsible,death,including,oxidative,stress,mitochondrial,dysfunction,glutamate,excitotoxicity,neuroinflammation,Casson
AB值:
0.715986
相似文献
Spirulina platensis aqueous extracts ameliorate colonic mucosal damage and modulate gut microbiota disorder in mice with ulcerative colitis by inhibiting inflammation and oxidative stress
Jian WANG;Liqian SU;Lun ZHANG;Jiali ZENG;Qingru CHEN;Rui DENG;Ziyan WANG;Weidong KUANG;Xiaobao JIN;Shuiqing GUI;Yinghua XU;Xuemei LU-Guangdong Provincial Key Laboratory of Pharmaceutical Bioactive Substances,School of Life Science and Biopharmaceutics,Guangdong Pharmaceutical University,Guangzhou 510006,China;School of Pharmacy,Guangdong Pharmaceutical University,Guangzhou 510006,China;Intensive Care Unit,Shenzhen Second People's Hospital,the First Affiliated Hospital of Shenzhen University,Shenzhen 518031,China;Key Laboratory of the Ministry of Health for Research on Quality and Standardization of Biotech Products,National Institutes for Food and Drug Control,Beijing 102629,China
Common mtDNA variations at C5178a and A249d/T6392C/G10310A decrease the risk of severe COVID?19 in a Han Chinese population from Central China
Yi Wu;Xian‑Hui Wang;Xi‑Hua Li;Li‑Yuan Song;Shi‑Long Yu;Zhi‑Cheng Fang;Yu‑Quan Liu;Le‑Yong Yuan;Chun‑Yan Peng;Shen‑Yi Zhang;Wang Cheng;Hong‑Chao Ma;Li‑Feng Wang;Jun‑Ming Tang;Yun‑Fu Wang;Fu‑Yun Ji-Department of Medical Biology,School of Basic Medical Science,Hubei University of Medicine,Shiyan 442000,Hubei,China;Institute of Biomedical Research,Hubei University of Medicine,Shiyan 442000,Hubei,China;Institute of Human Respiratory Disease,Xinqiao Hospital,The Army Medical University(Third Military Medical University),400037 Chongqing,China;Department of Emergency Medicine,Taihe Hospital,Hubei University of Medicine,Shiyan 442000,Hubei,China;Department of Geriatric Medicine,Taihe Hospital,Hubei University of Medicine,Shiyan 442000,Hubei,China;Department of Immunology,School of Basic Medical Sciences,Hubei University of Medicine,Shiyan 442000,Hubei,China;Department of Laboratory Medicine,Taihe Hospital,Hubei University of Medicine,Shiyan 442000,Hubei,China;Hubei Key Laboratory of Embryonic Stem Cell Research,School of Basic Medical Science,Hubei University of Medicine,Shiyan 442000,Hubei,China;Department of Neurology,Taihe Hospital,Hubei University of Medicine,Shiyan 442000,Hubei,China
Bone metastasis of hepatocellular carcinoma:facts and hopes from clinical and translational perspectives
Zhao Huang;Jingyuan Wen;Yufei Wang;Shenqi Han;Zhen Li;Xuemei Hu;Dongling Zhu;Zhenxiong Wang;Junnan Liang;Huifang Liang;Xiao-ping Chen;Bixiang Zhang-Hepatic Surgery Center,Tongji Hospital,Tongji Medical College,Huazhong University of Science and Technology,Wuhan 430030,China;Clinical Medical Research Center of Hepatic Surgery at Hubei Province,Wuhan 430030,China;Hubei Key Laboratory of Hepato-Pancreatic-Biliary Diseases,Tongji Hospital,Tongji Medical College,Huazhong University of Science and Technology,Wuhan 430030,China;Department of Radiology,Tongji Hospital,Tongji Medical College,Huazhong University of Science and Technology,Wuhan 430030,China;Department of Nuclear Medicine and PET Tongji Hospital,Tongji Medical College,Huazhong University of Science and Technology,Wuhan 430030,China;Department of Radiology,Guangzhou First People's Hospital,School of Medicine,South China University of Technology,Guangzhou 510180,China;Key Laboratory of Organ Transplantation,Ministry of Education;Key Laboratory of Organ Transplantation,National Health Commission;Key Laboratory of Organ Transplantation,Chinese Academy of Medical Sciences,Wuhan 430030,China
Corynoxine B derivative CB6 prevents Parkinsonian toxicity in mice by inducing PIK3C3 complex-dependent autophagy
Zhou Zhu;Liang-feng Liu;Cheng-fu Su;Jia Liu;Benjamin Chun-Kit Tong;Ashok lyaswamy;Senthilkumar Krishnamoorthi;Sravan Gopalkrishnashetty Sreenivasmurthy;Xin-jie Guan;Yu-xuan Kan;Wen-jian Xie;Chen-liang Zhao;King-ho Cheung;Jia-hong Lu;Jie-qiong Tan;Hong-jie Zhang;Ju-xian Song;Min Li-Mr.&Mrs.Ko Chi-Ming Centre for Parkinson's Disease Research,School of Chinese Medicine,Hong Kong Baptist University,Hong Kong,SAR,China;School of Chinese Medicine,Hong Kong Baptist University,Hong Kong,SAR,China;institute for Research and Continuing Education,Hong Kong Baptist University,Shenzhen 518057,China;Limin Pharmaceutical Factory,Livzon Group Limited,Shaoguan 512028,China;State Key Laboratory of Quality Research in Chinese Medicine,Institute of Chinese Medical Sciences,University of Macau,Macau,SAR,China;Center for Medical Genetics and Hunan Key Laboratory of Animal Model for Human Diseases,School of Life Sciences,Central South University,Changsha 410078,China;Medical College of Acupuncture-Moxibustion and Rehabilitation,Guangzhou University of Chinese Medicine,Guangzhou 510006,China
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。